| Product Code: ETC7904253 | Publication Date: Sep 2024 | Updated Date: Nov 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Sumit Sagar | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
In 2024, Latvia saw a significant increase in allopurinol import shipments, with top exporting countries being China, Poland, Ukraine, Germany, and India. The market remains highly concentrated, as indicated by the high Herfindahl-Hirschman Index (HHI). Despite a remarkable compound annual growth rate (CAGR) of 47.56% from 2020 to 2024, there was a notable decrease in growth rate from 2023 to 2024 at -41.38%. This suggests a potential shift in market dynamics or external factors impacting the import of allopurinol into Latvia.

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Latvia Allopurinol Market Overview |
3.1 Latvia Country Macro Economic Indicators |
3.2 Latvia Allopurinol Market Revenues & Volume, 2021 & 2031F |
3.3 Latvia Allopurinol Market - Industry Life Cycle |
3.4 Latvia Allopurinol Market - Porter's Five Forces |
3.5 Latvia Allopurinol Market Revenues & Volume Share, By Drug Class, 2021 & 2031F |
3.6 Latvia Allopurinol Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.7 Latvia Allopurinol Market Revenues & Volume Share, By Dosage Form, 2021 & 2031F |
3.8 Latvia Allopurinol Market Revenues & Volume Share, By End-Users, 2021 & 2031F |
3.9 Latvia Allopurinol Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 Latvia Allopurinol Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of gout and other related conditions in Latvia |
4.2.2 Growing awareness about the benefits of allopurinol in managing gout |
4.2.3 Rising geriatric population in Latvia leading to higher demand for gout medications |
4.3 Market Restraints |
4.3.1 Stringent government regulations on pharmaceuticals and healthcare products |
4.3.2 Competition from alternative treatments for gout |
4.3.3 Limited healthcare infrastructure in some regions of Latvia affecting distribution and access to allopurinol |
5 Latvia Allopurinol Market Trends |
6 Latvia Allopurinol Market, By Types |
6.1 Latvia Allopurinol Market, By Drug Class |
6.1.1 Overview and Analysis |
6.1.2 Latvia Allopurinol Market Revenues & Volume, By Drug Class, 2021- 2031F |
6.1.3 Latvia Allopurinol Market Revenues & Volume, By Antigout Agents, 2021- 2031F |
6.1.4 Latvia Allopurinol Market Revenues & Volume, By Antihyperuricemic Agents, 2021- 2031F |
6.2 Latvia Allopurinol Market, By Application |
6.2.1 Overview and Analysis |
6.2.2 Latvia Allopurinol Market Revenues & Volume, By Gout, 2021- 2031F |
6.2.3 Latvia Allopurinol Market Revenues & Volume, By Kidney Stones, 2021- 2031F |
6.2.4 Latvia Allopurinol Market Revenues & Volume, By Others, 2021- 2031F |
6.2.5 Latvia Allopurinol Market Revenues & Volume, By Demographic, 2021- 2031F |
6.2.6 Latvia Allopurinol Market Revenues & Volume, By Adult, 2021- 2031F |
6.2.7 Latvia Allopurinol Market Revenues & Volume, By Pediatric, 2021- 2031F |
6.3 Latvia Allopurinol Market, By Dosage Form |
6.3.1 Overview and Analysis |
6.3.2 Latvia Allopurinol Market Revenues & Volume, By Intravenous Powder for Injection, 2021- 2031F |
6.3.3 Latvia Allopurinol Market Revenues & Volume, By Oral Tablet, 2021- 2031F |
6.4 Latvia Allopurinol Market, By End-Users |
6.4.1 Overview and Analysis |
6.4.2 Latvia Allopurinol Market Revenues & Volume, By Clinic, 2021- 2031F |
6.4.3 Latvia Allopurinol Market Revenues & Volume, By Hospital, 2021- 2031F |
6.4.4 Latvia Allopurinol Market Revenues & Volume, By Others, 2021- 2031F |
6.5 Latvia Allopurinol Market, By Distribution Channel |
6.5.1 Overview and Analysis |
6.5.2 Latvia Allopurinol Market Revenues & Volume, By Hospital Pharmacy, 2021- 2031F |
6.5.3 Latvia Allopurinol Market Revenues & Volume, By Retail Pharmacy, 2021- 2031F |
6.5.4 Latvia Allopurinol Market Revenues & Volume, By Online Pharmacy, 2021- 2031F |
7 Latvia Allopurinol Market Import-Export Trade Statistics |
7.1 Latvia Allopurinol Market Export to Major Countries |
7.2 Latvia Allopurinol Market Imports from Major Countries |
8 Latvia Allopurinol Market Key Performance Indicators |
8.1 Prescription rates of allopurinol by healthcare providers in Latvia |
8.2 Patient adherence rates to allopurinol treatment regimens |
8.3 Number of new research studies or clinical trials on allopurinol efficacy and safety in Latvia |
9 Latvia Allopurinol Market - Opportunity Assessment |
9.1 Latvia Allopurinol Market Opportunity Assessment, By Drug Class, 2021 & 2031F |
9.2 Latvia Allopurinol Market Opportunity Assessment, By Application, 2021 & 2031F |
9.3 Latvia Allopurinol Market Opportunity Assessment, By Dosage Form, 2021 & 2031F |
9.4 Latvia Allopurinol Market Opportunity Assessment, By End-Users, 2021 & 2031F |
9.5 Latvia Allopurinol Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 Latvia Allopurinol Market - Competitive Landscape |
10.1 Latvia Allopurinol Market Revenue Share, By Companies, 2024 |
10.2 Latvia Allopurinol Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here